Brandywine Global Investment Management, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 118 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 3.27 and the average weighting 0.2%.

Quarter-by-quarter ownership
Brandywine Global Investment Management, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$6,747,924
+14.0%
435,631
+17.3%
0.05%
+16.3%
Q1 2024$5,919,845
+97.3%
371,383
+108.0%
0.04%
+79.2%
Q4 2023$3,001,089
+18.2%
178,530
-17.8%
0.02%
+9.1%
Q3 2023$2,539,173
-11.1%
217,209
+2.2%
0.02%
-8.3%
Q2 2023$2,856,121
-59.7%
212,509
-50.2%
0.02%
-17.2%
Q1 2023$7,079,958
+78.3%
427,018
+100.0%
0.03%
-6.5%
Q4 2022$3,971,267
+45.0%
213,5090.0%0.03%
+19.2%
Q3 2022$2,739,000
+75.8%
213,509
-3.9%
0.03%
+85.7%
Q2 2022$1,558,000
-26.2%
222,267
-12.7%
0.01%
-6.7%
Q1 2022$2,111,000
+22.4%
254,6670.0%0.02%
+25.0%
Q4 2021$1,724,000
-7.5%
254,667
-27.6%
0.01%
-14.3%
Q3 2021$1,864,000
-7.3%
351,642
+0.6%
0.01%
-6.7%
Q2 2021$2,010,000
+23.2%
349,628
-1.2%
0.02%
+25.0%
Q1 2021$1,631,000
+36.7%
353,887
-1.0%
0.01%
+20.0%
Q4 2020$1,193,000
-10.7%
357,325
-20.5%
0.01%
-23.1%
Q3 2020$1,336,000
-15.2%
449,680
+32.0%
0.01%
-18.8%
Q2 2020$1,575,000
+21.2%
340,790
+1.0%
0.02%0.0%
Q1 2020$1,300,000
+2.8%
337,562
+0.6%
0.02%
+77.8%
Q4 2019$1,265,000
-15.4%
335,412
+19.1%
0.01%
-18.2%
Q3 2019$1,496,000
+11.6%
281,677
-19.3%
0.01%
+22.2%
Q2 2019$1,341,000
+23.1%
349,072
+63.5%
0.01%
+12.5%
Q1 2019$1,089,000213,4750.01%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Broadfin Capital, LLC 7,097,300$27,750,0004.54%
GREAT POINT PARTNERS LLC 3,817,288$14,926,0002.55%
TANAKA CAPITAL MANAGEMENT INC 256,593$1,003,0002.29%
Consonance Capital Management LP 4,473,607$17,492,0001.58%
Avoro Capital Advisors LLC 3,892,343$15,219,0000.99%
KNOTT DAVID M 380,110$1,486,0000.59%
EAM Investors, LLC 790,872$3,092,0000.55%
Ghost Tree Capital, LLC 550,000$2,151,0000.50%
EAM Global Investors LLC 251,647$984,0000.50%
MANGROVE PARTNERS IM, LLC 924,648$3,615,0000.49%
View complete list of CATALYST PHARMACEUTICALS INC shareholders